Publications – Gunilla Enblad

Publications in DiVA

Publications in PubMed


Selected publications:

  1. Picropodophyllin (PPP) inhibits proliferation and survival of diffuse large B-cell lymphoma (DLBCL) cells. Strömberg T, Feng X, Delforoush M, Berglund M, Lin Y, Axelson M, Larsson O, Hemming P, Enblad G. Med Oncol. 2015;32(7):630.
     
  2. Donor or recipient origin of post-transplant lymphoproliferative disorders following solid organ transplantation. Kinch, A., Cavelier, L., Bengtsson, M., Baecklund, E., Enblad, G., Backlin, C., Thunberg, U., Sundström, C., Pauksens, K. Am J Transplant. 2014;14(12):2838-45.
     
  3. Diffuse large B-cell lymphomas in an unselected population - impact of age at diagnosis on survival. G Hedström, O Hagberg, M Jerkeman, G Enblad. Acta Oncologica 2014;18:1-8.
     
  4. A population-based study of 135 cases of lymphoma after solid organ transplantation: Impact of Epstein-Barr virus infection and B-cell origin of DLBCL on outcome. A Kinch, E Baecklund, C Backlin, T Ekman, K Ekström Smedby, D Molin, G Tufvesson, C Sundström, K Pauksens, G Enblad. Acta Oncol. 2014;53(5):669-79.
     
  5. Predictors for histology, tissue eosinophilia and mast cell infiltration in Hodgkin lymphoma – a population based study. Glimelius, I., Eriksson, J., Rostgaard, K., Amini, RM., Simonsson, M., Sorensen, KM., Ekström-Smedby, K., Venge, P., Hjalgrim, H., Molin, D, Enblad, G. Eur J Haematol. 2011;87(3):208-216.
     
  6. p53 mutations in de novo diffuse large B cell lymphoma and the relationship to p53 codon 72 polymorphisms and MDM2 SNP309. N Zainuddin, M Berglund, R-M Amini, R Rosenquist Brandell, G Enblad. Leuk Res. 2009;33(1):60-6.
     
  7. Inflammatory cells and microenvironment in malignant lymphoma. D de Jong and G Enblad. J Intern Med. 2008;264(6):528-36.
     
  8. Family history of cancer as a risk factor for second malignancies after Hodgkin's lymphoma. A Andersson, G Enblad, B Tavelin, M Björkholm, A Gustafsson, A Håkansson, I Lagerlöf, M Merup, M Sender, B Malmer. Br J Cancer. 2008;98(5):1001-5.
     
  9. Prognostic impact of immunohistochemically defined germinal center phenotype in diffuse large B-cell lymphoma patients treated with immunochemotherapy. H Nyman, M Adde, M-L Karjalainen-Lindsberg, M Taskinen, M Berglund, R-M Amini, C Blomqvist, G Enblad, and S Leppä. Blood. 2007;109(11):4930-5.
     
  10. Evaluation of immunophenotype in Diffuse Large B-Cell Lymphoma and impact on prognosis. M Berglund, U Thunberg, R-M Amini, M Book, C Backlin, G Roos, M Erlanson J Linderoth, M Dictor, M Jerkeman, E Cavallin-Ståhl, C Sundström, S Rehn-Eriksson, H Hagberg, R Rosenquist, and G Enblad. Mod Pathol. 2005;18(8):1113-20.